![Brian David Grossman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian David Grossman
Directeur Général chez
PFM Health Sciences LP
Profil
Mr. Brian D.
Grossman, CFA, is a Managing Partner, Chief Investment Officer & Portfolio Manager at PFM Health Sciences LP.
He was a Founding Partner of Partner Fund Management (PFM) in 2004 where he was the co-portfolio manager for a diversified strategy and the sole portfolio manager for the healthcare strategy.
In 2020, he became PFM’s sole managing partner and the firm changed its name to PFM Health Sciences.
He is a member of the University of California San Francisco (UCSF) Board of Observers and co-chair of the UCSF Health Executive Council, which evaluates business strategies, operations, and financial performance for UCSF Health.
Before joining the firm, Mr. Grossman was an Investment Analyst focusing on biotech at Pequot Capital (2001) and Andor Capital (2001-2004).
He started his career at J.P.
Morgan Investment Management (JPMIM) as a Convertible Bond Analyst (1996-1998) and as a Healthcare Equity Research Analyst (1998-2001).
He is a graduate of The University of Pennsylvania with a B.S.
in Economics and is a CFA charterholder.
Postes actifs de Brian David Grossman
| Sociétés | Poste | Début |
|---|---|---|
PFM Health Sciences LP
 PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies. | Directeur Général | 01/09/2004 |
Formation de Brian David Grossman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
PFM Health Sciences LP
PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies. | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
